NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyPilot Studies: Oral Complications of Cancer Therapies (R21)
About This Grant
The National Institute of Dental and Craniofacial Research (NIDCR) and the National Cancer Institute (NCI) invite applications for clinical research directed at reducing the incidence and severity of oral complications from cancer therapies. The purpose of these studies would be to collect preliminary data to establish an adequate foundation that may lead to R01-level clinical research grants.
Grant Summary
Pilot Studies: Oral Complications of Cancer Therapies (R21) is a National Institutes of Health grant providing up to $200K for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $200K
Rolling / Open
- 1Confirm your organization is eligible for Pilot Studies: Oral Complications of Cancer Therapies (R21) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Pilot Studies: Oral Complications of Cancer Therapies (R21): Frequently Asked Questions
Who is eligible for the Pilot Studies: Oral Complications of Cancer Therapies (R21)?
Pilot Studies: Oral Complications of Cancer Therapies (R21) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Pilot Studies: Oral Complications of Cancer Therapies (R21) provide?
Pilot Studies: Oral Complications of Cancer Therapies (R21) provides up to $200K per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Pilot Studies: Oral Complications of Cancer Therapies (R21) deadline?
Pilot Studies: Oral Complications of Cancer Therapies (R21) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Pilot Studies: Oral Complications of Cancer Therapies (R21)?
To apply for Pilot Studies: Oral Complications of Cancer Therapies (R21), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.